Substrate mediated enzyme prodrug therapy.
In this report, we detail Substrate Mediated Enzyme Prodrug Therapy (SMEPT) as a novel approach in drug delivery which relies on enzyme-functionalized cell culture substrates to achieve a localized conversion of benign prodrug(s) into active therapeutics with subsequent delivery to adhering cells or...
Main Authors: | Betina Fejerskov, Alexander N Zelikin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3496709?pdf=render |
Similar Items
-
Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy
by: Ashraf S.A. El-Sayed, et al.
Published: (2022-09-01) -
Enzyme-mediated hydrolytic activation of prodrugs
by: Yan-hui Yang, et al.
Published: (2011-10-01) -
Computational Simulations to Guide Enzyme-Mediated Prodrug Activation
by: Milica Markovic, et al.
Published: (2020-05-01) -
Lectin-directed enzyme activated prodrug therapy (LEAPT): Synthesis and evaluation of rhamnose-capped prodrugs.
by: Garnier, P, et al.
Published: (2010) -
LEAPT: lectin-directed enzyme-activated prodrug therapy.
by: Robinson, M, et al.
Published: (2004)